{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:41:12Z","timestamp":1793868072847,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.euo.2025.04.017","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T01:10:00Z","timestamp":1749690600000},"page":"1393-1405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combined Prostate-specific Membrane Antigen Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer"],"prefix":"10.1016","volume":"8","author":[{"given":"Kit Mun","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Peh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Guang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae Jack","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Ping","family":"Thang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Tuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Law Yan","family":"Mee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thane","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Yan","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.04.017_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0010","first-page":"1","article-title":"Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001\u201304","volume":"379","author":"Lacher","year":"2006","journal-title":"Adv Data"},{"key":"10.1016\/j.euo.2025.04.017_b0015","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM200105033441806","article-title":"Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer","volume":"344","author":"Barry","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.04.017_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fmed.2017.00157","article-title":"Prognostic value of the new prostate cancer international society of urological pathology grade groups","volume":"4","author":"Offermann","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.euo.2025.04.017_b0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2025.04.017_b0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.04.017_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2020190646","article-title":"Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel","volume":"296","author":"Westphalen","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.04.017_b0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/bco2.184","article-title":"Performance of multiparametric prostate magnetic resonance imaging validated by targeted and systematic transperineal biopsies","volume":"4","author":"Hsi","year":"2023","journal-title":"BJUI Compass"},{"key":"10.1016\/j.euo.2025.04.017_b0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouviere","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.04.017_b0055","article-title":"Evaluating medical tests: introducing the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy","volume":"7","author":"Bossuyt","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euo.2025.04.017_b0060","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","article-title":"Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers\u2014part II. Statistical methods of meta-analysis","volume":"16","author":"Lee","year":"2015","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.euo.2025.04.017_b0065","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jclinepi.2012.03.006","article-title":"Bivariate meta-analysis of predictive values of diagnostic tests can be an alternative to bivariate meta-analysis of sensitivity and specificity","volume":"65","author":"Leeflang","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euo.2025.04.017_b0070","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.euo.2025.04.017_b0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.euo.2025.04.017_b0080","unstructured":"AJ V. Decision curve analysis; 2023. https:\/\/mskcc-epi-bio.github.io\/decisioncurveanalysis\/dca-tutorial.html."},{"key":"10.1016\/j.euo.2025.04.017_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"10.1016\/j.euo.2025.04.017_b0090","doi-asserted-by":"crossref","unstructured":"Sjoberg DD. Decision curve analysis for model evaluation; 2022.","DOI":"10.32614\/CRAN.package.dcurves"},{"key":"10.1016\/j.euo.2025.04.017_b0095","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1007\/s00259-021-05355-7","article-title":"Detection of clinically significant prostate cancer with (18)F-DCFPyL PET\/multiparametric MR","volume":"48","author":"Metser","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.04.017_b0100","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2214\/AJR.17.18881","article-title":"Effect of combined (68)Ga-PSMAHBED-CC uptake pattern and multiparametric MRI derived with simultaneous PET\/MRI in the diagnosis of primary prostate cancer: initial experience","volume":"210","author":"Taneja","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.euo.2025.04.017_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.euo.2025.04.017_b0110","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euo.2025.04.017_b0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1754-9485.13029","article-title":"Review of the accuracy of multi-parametric MRI prostate in detecting prostate cancer within a local reporting service","volume":"64","author":"Tsai","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.euo.2025.04.017_b0120","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.3390\/diagnostics13162697","article-title":"Prostate MRI and PSMA-PET in the primary diagnosis of prostate cancer","volume":"13","author":"Cereser","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.euo.2025.04.017_b0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.semnuclmed.2023.10.002","article-title":"PSMA PET\/CT Versus mpMRI for the detection of clinically significant prostate cancer: an updated overview","volume":"54","author":"Caracciolo","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.euo.2025.04.017_b0130","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1097\/RLU.0000000000005265","article-title":"Comparison of multiparametric MRI and the combination of PSMA plus MRI for the intraprostatic diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"49","author":"Brondani Torri","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.euo.2025.04.017_b0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/ua.ua_22_22","article-title":"False-positive magnetic resonance imaging prostate cancer correlates and clinical implications","volume":"15","author":"Arafa","year":"2023","journal-title":"Urol Ann"},{"key":"10.1016\/j.euo.2025.04.017_b0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.03.014","article-title":"PRECISE version 2: updated recommendations for reporting prostate magnetic resonance imaging in patients on active surveillance for prostate cancer","volume":"86","author":"Englman","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.euo.2020.09.002","article-title":"Can the use of serial multiparametric magnetic resonance imaging during active surveillance of prostate cancer avoid the need for prostate biopsies?\u2014A systematic diagnostic test accuracy review","volume":"4","author":"Hettiarachchi","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.04.017_b0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/pcan.2017.8","article-title":"Patient selection for prostate focal therapy in the era of active surveillance: an international Delphi consensus project","volume":"20","author":"Tay","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.04.017_b0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2018.01.001","article-title":"Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018","volume":"74","author":"van der Poel","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0160","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/JU.0000000000001126","article-title":"High intensity focused ultrasound hemigland ablation for prostate cancer: initial outcomes of a United States series","volume":"204","author":"Abreu","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4111\/icu.20210472","article-title":"Focal therapy for prostate cancer with irreversible electroporation: oncological and functional results of a single institution study","volume":"63","author":"Yaxley","year":"2022","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0170","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41391-021-00369-6","article-title":"Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control","volume":"24","author":"van Son","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl 4","key":"10.1016\/j.euo.2025.04.017_b0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bju.16207","article-title":"Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy","volume":"133","author":"Geboers","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.04.017_b0180","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1007\/s00330-017-4877-x","article-title":"Prostate-specific membrane antigen PET\/MRI validation of MR textural analysis for detection of transition zone prostate cancer","volume":"27","author":"Bates","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2025.04.017_b0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/JU.0000000000004010","volume":"212","author":"Emmett","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0190","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0195","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.euo.2021.02.006","article-title":"Combined utility of (68)Ga-prostate-specific membrane antigen positron emission tomography\/computed tomography and multiparametric magnetic resonance imaging in predicting prostate biopsy pathology","volume":"5","author":"Kalapara","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.04.017_b0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.2021204093","article-title":"Diagnostic performance of (68)Ga prostate-specific membrane antigen PET\/MRI compared with multiparametric MRI for detecting clinically significant prostate cancer","volume":"301","author":"Margel","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.04.017_b0205","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.7150\/thno.58140","article-title":"Establishment and prospective validation of an SUV(max) cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by (68)Ga-PSMA PET\/CT: a real-world study","volume":"11","author":"Jiao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.euo.2025.04.017_b0210","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.21873\/invivo.13211","article-title":"(68)Ga-PSMA PET\/CT and prostate cancer diagnosis: which SUVmax value?","volume":"37","author":"Pepe","year":"2023","journal-title":"In Vivo"},{"key":"10.1016\/j.euo.2025.04.017_b0215","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-023-00182-5","article-title":"Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway","volume":"7","author":"Sharma","year":"2023","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.euo.2025.04.017_b0220","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00259-024-06949-7","article-title":"Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS\u2009\u2264\u20093 MRI","volume":"52","author":"Li","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.04.017_b0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2967\/jnumed.123.266742","article-title":"The value of (68)Ga-PSMA PET\/MRI for classifying patients with PI-RADS 3 lesions on multiparametric MRI: a prospective single-center study","volume":"65","author":"Shi","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2025.04.017_b0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JU.0000000000004025","volume":"212","author":"Niu","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.04.017_b0235","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00259-021-05261-y","article-title":"Diagnostic performance of (68)Ga-PSMA-11 PET\/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study","volume":"48","author":"Ferraro","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.04.017_b0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/RLU.0000000000004951","article-title":"The PRIMARY score: diagnostic performance and added value compared with MRI in detecting clinically significant prostate cancer","volume":"49","author":"Guo","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.euo.2025.04.017_b0245","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11307-023-01841-6","article-title":"PI-RADS-based segmented threshold of PSMA-PET SUVmax is better than traditional fixed threshold for diagnosing clinically significant prostate cancer especially for PI-RADS 3 lesions","volume":"25","author":"Meng","year":"2023","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.euo.2025.04.017_b0250","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.euo.2024.01.002","article-title":"Fluorine-18\u2013labelled prostate-specific membrane antigen positron emission tomography\/computed tomography or magnetic resonance imaging to diagnose and localise prostate cancer. A prospective single-arm paired comparison (PEDAL)","volume":"7","author":"Wong","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.04.017_b0255","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.118.221010","article-title":"Combination of (68)Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: a lesion-by-lesion analysis","volume":"60","author":"Chen","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2025.04.017_b0260","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/ijnm.ijnm_80_21","volume":"36","author":"Kubihal","year":"2021","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.euo.2025.04.017_b0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.euros.2022.11.012","article-title":"Multiparametric magnetic resonance imaging of the prostate and prostate-specific membrane positron emission tomography prior to prostate biopsy (MP4 Study)","volume":"47","author":"Woo","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2025.04.017_b0270","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00259-021-05604-9","article-title":"Prospective analysis of clinically significant prostate cancer detection with [(18)F]DCFPyL PET\/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study","volume":"49","author":"Bodar","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.04.017_b0275","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3390\/cancers16091777","article-title":"\u201cSeeing is believing\u201d: additive utility of (68)Ga-PSMA-11 PET\/CT in prostate cancer diagnosis","volume":"16","author":"Chin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2025.04.017_b0280","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.2018180788","article-title":"Diagnostic accuracy of (68)Ga-PSMA-11 PET\/MRI compared with multiparametric MRI in the detection of prostate cancer","volume":"289","author":"Hicks","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.04.017_b0285","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/MNM.0000000000001743","article-title":"Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [68Ga]PSMA-11-PET and [11C]acetate-PET","volume":"44","author":"Sandgren","year":"2023","journal-title":"Nucl Med Commun"},{"issue":"Suppl 1","key":"10.1016\/j.euo.2025.04.017_b0290","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bju.14794","volume":"124","author":"Scheltema","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.04.017_b0295","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2967\/jnumed.121.262398","volume":"63","author":"Sonni","year":"2022","journal-title":"J Nucl Med"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:35:18Z","timestamp":1766511318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125001087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2588931125001087"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.017","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Prostate-specific Membrane Antigen Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}